Interstitial fluid glucose concentration

Interstitial fluid glucose concentration refers to the amount of glucose present in the interstitial fluid, which is the liquid that surrounds cells throughout the body. This compartment acts as an intermediary between blood plasma and cellular interiors. Glucose enters the interstitial space from capillaries by diffusion along its concentration gradient before being taken up by cells for metabolism. The measurement of this parameter has become central to modern diabetes care through continuous glucose monitoring (CGM) devices, which use subcutaneous sensors to estimate real-time trends in tissue-level glycemia. There is typically a time lag—ranging from about 5–25 minutes—between changes observed in blood versus those detected within the interstitial compartment due to physiological kinetics; this means CGM readings may trail behind actual blood sugar fluctuations, particularly during rapid rises or falls such as after eating or exercise. Furthermore, while often used interchangeably with “blood sugar,” interstitial fluid measurements are not identical; they represent related but distinct physiological compartments with complex dynamic relationships that can be influenced by factors like insulin action and tissue uptake rates. Because "interstitial fluid glucose concentration" describes a measured variable rather than an actionable molecular entity such as an enzyme or receptor, it is not considered a therapeutic target, nor does it have canonical abbreviations typical of protein/gene targets. It serves instead as an important clinical biomarker for patient monitoring and therapy adjustment.

Other names

Interstitial glucoseISF glucoseGlucose in interstitial fluidSubcutaneous interstitial glucose concentration